Adjusting for multiple testing--when and how? (Q34215794)

31 July 2017

1 reference

title

Adjusting for multiple testing--when and how? (English)

1 reference

31 July 2017

Bender R

1

1 reference

PubMed ID

11297884

31 July 2017

Lange S

series ordinal

2

1 reference

31 July 2017

1 April 2001

1 reference

Journal of Clinical Epidemiology

31 July 2017

1 reference

31 July 2017

54

1 reference

31 July 2017

4

1 reference

31 July 2017

343-349

1 reference

Some comments on frequently used multiple endpoint adjustment methods in clinical trials

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products. CPMP Working Party on Efficacy of Medicinal Products Note for Guidance III/3630/92-EN

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

No adjustments are needed for multiple comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Multiple comparisons and related issues in the interpretation of epidemiologic data

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Describing data requires no adjustment for multiple comparisons: a reply from Savitz and Olshan

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

What's wrong with Bonferroni adjustments

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Other method for adjustment of multiple testing exists

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Multiple test procedures other than Bonferroni's deserve wider use.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Multiple testing in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Invited commentary: Re: "Multiple comparisons and related issues in the interpretation of epidemiologic data".

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Multiple comparisons, explained

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

The appropriateness of analysis of variance and multiple-comparison procedures.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Multiple significance tests: the Bonferroni method

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

On the Holm, Simes, and Hochberg multiple test procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

On closed testing procedures with special reference to ordered analysis of variance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Comparing several groups using analysis of variance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Statistics in practice. Comparing the means of several groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Pairwise multiple comparison procedures: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

New developments in pairwise multiple comparisons: Some powerful and practicable procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Some statistical methods for multiple endpoints in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Procedures for comparing samples with multiple endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

The analysis of multiple endpoints in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Multivariate tests for multiple endpoints in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

P-value interpretation and alpha allocation in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Alpha calculus in clinical trials: considerations and commentary for the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Analysis of serial measurements in medical research

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Repeated measures in clinical trials: simple strategies for analysis using summary measures

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

On multiple comparisons in the randomization analysis of growth and response curves

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

A consumer's guide to subgroup analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

The problem of cogent subgroups: a clinicostatistical tragedy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Analysis of clinical trial outcomes: some comments on subgroup analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Statistical and ethical issues in monitoring clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Group sequential testing in clinical trials with multivariate observations: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

The management of interim analyses in drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Repeated significance tests on accumulating survival data

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

The UK Prospective Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Empirical Bayes estimates of age-standardized relative risks for use in disease mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

Empirical-Bayes adjustments for multiple comparisons are sometimes useful

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900314-0

7 January 2021

10.1016/S0895-4356(00)00314-0

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11297884